Evolent Health (NYSE:EVH – Get Free Report) and BILL (NYSE:BILL – Get Free Report) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, dividends, valuation and analyst recommendations.
Valuation and Earnings
This table compares Evolent Health and BILL”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Evolent Health | $1.88 billion | 0.23 | -$534.51 million | ($5.15) | -0.76 |
| BILL | $1.46 billion | 2.59 | $23.80 million | ($0.24) | -159.60 |
Analyst Ratings
This is a breakdown of current recommendations and price targets for Evolent Health and BILL, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Evolent Health | 1 | 3 | 13 | 0 | 2.71 |
| BILL | 2 | 10 | 12 | 0 | 2.42 |
Evolent Health currently has a consensus price target of $6.04, indicating a potential upside of 54.79%. BILL has a consensus price target of $55.10, indicating a potential upside of 43.84%. Given Evolent Health’s stronger consensus rating and higher possible upside, analysts clearly believe Evolent Health is more favorable than BILL.
Profitability
This table compares Evolent Health and BILL’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Evolent Health | -28.49% | 1.49% | 0.49% |
| BILL | -1.56% | 1.70% | 0.66% |
Institutional and Insider Ownership
98.0% of BILL shares are held by institutional investors. 1.5% of Evolent Health shares are held by company insiders. Comparatively, 13.2% of BILL shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Volatility and Risk
Evolent Health has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500. Comparatively, BILL has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500.
Summary
BILL beats Evolent Health on 9 of the 14 factors compared between the two stocks.
About Evolent Health
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
About BILL
BILL Holdings, Inc. provides financial automation software for small and midsize businesses worldwide. The company provides software-as-a-service, cloud-based payments, and spend management products, which allow users to automate accounts payable and accounts receivable transactions, as well as enable users to connect with their suppliers and/or customers to do business, eliminate expense reports, manage cash flows, and improve office efficiency. It also offers onboarding implementation support, and ongoing support and training services. In addition, the company's artificial intelligence enabled software provides connections between suppliers and clients. It serves accounting firms, financial institutions, and software companies. The company was formerly known as Bill.com Holdings, Inc. and changed its name to BILL Holdings, Inc. in February 2023. BILL Holdings, Inc. was incorporated in 2006 and is headquartered in San Jose, California.
Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.
